Musculoskeletal oncology is a clinical specialty dealing with a diverse population of patients with metastatic bone disease, hematological malignancies with musculoskeletal manifestations, primary bone malignancies and soft tissue sarcomas. There are wide‐spread disparities including socioeconomic (SES) and insurance‐related disparities reported in the literature. In this review, we'll summarize the disparities surrounding the musculoskeletal oncology.